Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bea Kuiperij

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Neurology|April 20, 2011
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsyH Bea Kuiperij, Marcel M Verbeek
Neurobiology of Aging|October 16, 2010
Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?H Bea Kuiperij, Marcel M Verbeek
Current Drug Targets. CNS and Neurological Disorders|June 25, 2005
The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disordersFreek L van Muiswinkel, H Bea Kuiperij
Journal of Immunological Methods|May 1, 2012
Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocolMegan K Herbert, H Bea Kuiperij, Marcel M Verbeek
Methods in Enzymology|June 8, 2006
Biochemistry of the Rap-specific guanine nucleotide exchange factors PDZ-GEF1 and -2H Bea Kuiperij, Holger Rehmann, Fried J T Zwartkruis
BBA Clinical|December 18, 2015
A multifunctional ELISA to measure <b>oxidised</b> proteins: oxPin1 in Alzheimer's brain as an exampleMegan K Herbert, Marcel M Verbeek, Benno Küsters, et al.
Journal of Alzheimer'S Disease : JAD|December 14, 2011
Methods for analysis of amyloid-β aggregatesKim A Bruggink, Mareike Müller, H Bea Kuiperij, et al.
Journal of Alzheimer'S Disease : JAD|March 28, 2015
Cerebrospinal Fluid NrCAM is not a Suitable Biomarker to Discriminate between Dementia Disorders--A Pilot StudyMareike Müller, Jurgen A Claassen, H Bea Kuiperij, et al.
Neurology|August 4, 2011
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson diseaseKim A Bruggink, H Bea Kuiperij, Frida Ekholm-Pettersson, et al.
Journal of Neurology|October 15, 2013
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controlsMegan K Herbert, H Bea Kuiperij, Bastiaan R Bloem, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Neurology|April 20, 2011
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsyH Bea Kuiperij, Marcel M Verbeek
Neurobiology of Aging|October 16, 2010
Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?H Bea Kuiperij, Marcel M Verbeek
Current Drug Targets. CNS and Neurological Disorders|June 25, 2005
The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disordersFreek L van Muiswinkel, H Bea Kuiperij
Journal of Immunological Methods|May 1, 2012
Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocolMegan K Herbert, H Bea Kuiperij, Marcel M Verbeek
Methods in Enzymology|June 8, 2006
Biochemistry of the Rap-specific guanine nucleotide exchange factors PDZ-GEF1 and -2H Bea Kuiperij, Holger Rehmann, Fried J T Zwartkruis
BBA Clinical|December 18, 2015
A multifunctional ELISA to measure <b>oxidised</b> proteins: oxPin1 in Alzheimer's brain as an exampleMegan K Herbert, Marcel M Verbeek, Benno Küsters, et al.
Journal of Alzheimer'S Disease : JAD|December 14, 2011
Methods for analysis of amyloid-β aggregatesKim A Bruggink, Mareike Müller, H Bea Kuiperij, et al.
Journal of Alzheimer'S Disease : JAD|March 28, 2015
Cerebrospinal Fluid NrCAM is not a Suitable Biomarker to Discriminate between Dementia Disorders--A Pilot StudyMareike Müller, Jurgen A Claassen, H Bea Kuiperij, et al.
Neurology|August 4, 2011
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson diseaseKim A Bruggink, H Bea Kuiperij, Frida Ekholm-Pettersson, et al.
Journal of Neurology|October 15, 2013
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controlsMegan K Herbert, H Bea Kuiperij, Bastiaan R Bloem, et al.
Pageof 8